Global Clinical Affairs
Ms. Cabala’s 35 year career in the pharmaceutical industry has been highlighted by success after success in clinical trials and bringing ground breaking treatments to market. She has a strong record of achievement in big pharma at local, regional and international level in management, leadership, clinical research, strategic alliances and business development. Her specialty is ensuring high quality, timely and cost effective conduct of Phase l, ll, lll and lV clinical research programs in accordance with prevailing ICH/GCP and industry standards.
While building and leading Pfizer Australia’s clinical research effort, Ms Cabala successfully merged the early phase and late phase research efforts to create a more streamlined research environment and ensure that new treatments reached the clinical trial stage faster and with better results than ever before. Her efforts led to Pfizer team becoming the largest and most successful research team in the Southern Hemisphere. It also led to her department becoming the “Research Partner of Choice” throughout the world.
Kristina will use her collaborative experience with government and regulatory bodies, medical researchers and institutions to support and further develop Reven’s clinical research environment.